What is Artificial Heart Lung Machines Market?
Artificial Heart-Lung Machine, also known as cardiopulmonary bypass pump, is a device used in open-heart surgery to support the body during the surgical procedure while the heart is stopped. The heart-lung machine is often referred to as the pump and does the work for both the heart (i.e., pumps blood) and the lung operation. Thhe factors such as Increased Prevalence of Heart Diseases among People, Increasing Awareness about Healthy Lifestyle and Growth in the Healthcare Infrastructure in Developing Countries are driving the global artificial heart lung machines market.
The market study is being classified by Type (Single Roller Pump HLM and Double Roller Pump HLM), by Application (Cardiac Surgery, Lung Transplant Operation, Acute Respiratory Failure Treatment and Others) and major geographies with country level break-up.
Medtronic Inc. (Ireland), Sorin Group (Italy), MAQUET GmbH & Co. KG (Germany), Terumo Corporation (Japan), C. R. Bard Inc. (United States), Edwards Lifesciences (United States), Braile Biomedica (Brazil), SynCardia Systems, LLC (United States), LivaNova PLC (Spain) and Getinge (Sweden) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Medtronic plc (Ireland) and Braile Biomedica (Brazil).
The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Artificial Heart Lung Machines market throughout the predicted period.
Analyst at AMA have segmented the market study of Global Artificial Heart Lung Machines market by Type, Application and Region.
On the basis of geography, the market of Artificial Heart Lung Machines has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Increased Prevalence of Heart Diseases among People
- Increasing Awareness about Healthy Lifestyle
- Growth in the Healthcare Infrastructure in Developing Countries
- Robust Increase in the Distribution Channels
- Increasing Number of Hospitals and Clinics
- Dearth of Skilled Workforce
- Increasing Number of Geriatric Population
- Rise in the Government Funding for Research and Development Activities
- Increasing Demand from End-users
- Stringent Government Rules and Regulations
In November 2019, Terumo Corporation has announced that it has decided to acquire Aortica Corporation, a U.S.-based company dedicated to advancing the science of personalized vascular therapy. Aortica has developed an automated case planning software known as AortaFit, designed to precisely match fenestrations on an endograft with the unique locations of each individual patient's branch arteries during Fenestrated Endovascular Aortic Repair (FEVAR).
Key Target AudienceArtificial Heart Lung Machines Manufacturers, Raw Material Suppliers, Distributors, Emerging Companies, Research Professionals and End-users
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase